Literature DB >> 17874096

Uncommon extent involvement of sarcoidosis in 18F-FDG PET/CT.

N Ozlem Küçük1, Elgin Ozkan, Gülseren Aras.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17874096     DOI： 10.1007/s00259-007-0555-6

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN： 1619-7070            Impact factor:   9.236


× No keyword cloud information.
  5 in total

1.  FDG PET in the clinical evaluation of sarcoidosis with bone lesions.

Authors:  A Kobayashi; T Shinozaki; Y Shinjyo; K Kato; N Oriuchi; H Watanabe; K Takagishi
Journal:  Ann Nucl Med       Date:  2000-08       Impact factor: 2.668

2.  F-18 FDG PET imaging of disseminated sarcoidosis.

Authors:  Ba D Nguyen
Journal:  Clin Nucl Med       Date:  2007-01       Impact factor: 7.794

3.  Value of FDG positron emission tomography in monitoring the effects of therapy in progressive pulmonary sarcoidosis.

Authors:  Kyoichi Kaira; Tamotsu Ishizuka; Noriko Yanagitani; Noriaki Sunaga; Takeshi Hisada; Masatomo Mori
Journal:  Clin Nucl Med       Date:  2007-02       Impact factor: 7.794

4.  FDG PET/CT demonstrated rapid progression of mediastinal lymphadenopathy in sarcoidosis.

Authors:  Cheng-Yi Cheng; Wen-Sheng Huang; Daniel H Shen; Yu-Ming Fan; Hsian-Her Hsu; Shiou-Chi Cherng; Shih-Chun Lee
Journal:  Clin Nucl Med       Date:  2007-02       Impact factor: 7.794

5.  [Sarcoidosis of the skeleton. Review of the literature and case report. (author's transl)].

Authors:  E Uehlinger; K Wurm
Journal:  Rofo       Date:  1976-08
  5 in total
  1 in total

1.  Early 2'-deoxy-2'-[18F]fluoro-D-glucose PET metabolic response after corticosteroid therapy to differentiate cancer from sarcoidosis and sarcoid-like lesions.

Authors:  Nicolas Aide; Djelila Allouache; Yann Ollivier; Sixtine de Raucourt; Odile Switsers; Stéphane Bardet
Journal:  Mol Imaging Biol       Date:  2009-03-31       Impact factor: 3.488
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.